These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1514146)

  • 21. Detection of the Philadelphia chromosome in paraffin-embedded tissue by fluorescence in situ hybridization.
    Brynes RK; McCourty A; Ho JP; Traweek ST; Snyder DS; Slovak ML
    Mod Pathol; 1994 Jun; 7(5):565-9. PubMed ID: 7937723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCR-ABL positive essential thrombocythaemia: a variant of chronic myelogerous leukaemia or a distinct clinical entity: a special case report.
    Fadilah SA; Cheong SK
    Singapore Med J; 2000 Dec; 41(12):595-8. PubMed ID: 11296785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Khoury H; Adkins D; Zehnbauer B; Goodnough L; Brown R; Safdar S; DiPersio JF
    Bone Marrow Transplant; 1998 Jul; 22(1):107-9. PubMed ID: 9678805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic myeloid leukemia--pathophysiology and diagnosis].
    Stoetzer OJ; Hentrich M; Salat C
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2618-20. PubMed ID: 12469274
    [No Abstract]   [Full Text] [Related]  

  • 25. Is very high platelet count always associated with essential thrombocythemia? An unusual presentation in a child.
    Aktekin EH; Yazici N; Kozanoğlu İ; Erbay A
    Lab Med; 2023 Nov; 54(6):e170-e176. PubMed ID: 37352366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Philadelphia-chromosome positive thrombocythemia in a child.
    Mishra P; Mahapatra M; Kumar R; Dixit A; Chatterjee T; Tyagi S; Choudhry DR; Sazawal S; Choudhry VP
    Eur J Haematol; 2005 Sep; 75(3):262-3. PubMed ID: 16104885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A myeloproliferative disorder may hide another one.
    Laibe S; Tadrist Z; Arnoulet C; Sainty D; Mozziconacci MJ
    Leuk Res; 2009 Aug; 33(8):1133-6. PubMed ID: 19250672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chronic myeloproliferative syndromes].
    de Ozalla CB; García Suárez J
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():28-36. PubMed ID: 10422448
    [No Abstract]   [Full Text] [Related]  

  • 30. [Report of 8 cases of bcr-abl gene positive thrombocytosis and review of the literature].
    Lin FR; Wang Y; Chen J
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):528-31. PubMed ID: 15569529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic myeloid leukemia. Diagnosis, course, prognosis].
    Lacotte-Thierry L; Guilhot F
    Rev Prat; 1999 Feb; 49(3):339-43. PubMed ID: 10189806
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of bcr-abl gene expression at a low level in blood cells of some patients with essential thrombocythemia.
    Hsu HC; Tan LY; Au LC; Lee YM; Lieu CH; Tsai WH; You JY; Liu MD; Ho CK
    J Lab Clin Med; 2004 Feb; 143(2):125-9. PubMed ID: 14966468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical use of the bcr/abl probe test in the evaluation of chronic myeloid leukemia patients.
    Yazici H; Sengün Z; Aktan M; Aktuglu G; Uskent N; Dalay N
    J Exp Clin Cancer Res; 1997 Mar; 16(1):105-9. PubMed ID: 9148870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic myeloid leukemia. Diagnosis, development and prognosis].
    Tanzer J
    Rev Prat; 1988 Jun; 38(18):1210-6. PubMed ID: 3175491
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinicopathological criteria for differential diagnosis of thrombocythemias in various myeloproliferative disorders.
    Thiele J; Kvasnicka HM
    Semin Thromb Hemost; 2006 Apr; 32(3):219-30. PubMed ID: 16673276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low incidence of familial occurrence of thrombocythaemia and/or thrombocytosis.
    Randi ML; Fabris F; Visentin I; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):695-9. PubMed ID: 2465250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and follow-up in chronic myeloid leukemia. Detection and quantification of specific transcripts with the help of reverse transcriptase-polymerase chain reaction].
    Osland A; Shammas FV; Heikkilä R
    Tidsskr Nor Laegeforen; 1996 Feb; 116(6):726-30. PubMed ID: 8644073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
    Pikman Y; Levine RL
    Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular construction of Philadelphia chromosome and its relation to the clinical features].
    Kamada N; Tanaka K; Asou H
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1098-105. PubMed ID: 2053768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon in the treatment of myeloproliferative diseases.
    Silver RT
    Semin Hematol; 1990 Jul; 27(3 Suppl 4):6-14. PubMed ID: 2115694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.